Roquette will showcase its end-to-end portfolio of pharmaceutical excipients, drug delivery solutions and technical expertise at CPHI Milan 2026 in Italy, where the company will welcome visitors at booth 1A18 in the excipients hall.
Emerson has announced an enhancement to its DeltaV Real-Time Scheduling (RTS) software that extends integrated, real-time manufacturing scheduling capabilities to quality control (QC) labs.
Bioiberica, a life science company, announces its return to CPHI Milan with a renewed mission to provide the high-quality, traceable and scientifically validated ingredients pharmaceutical and nutraceutical players need to unlock innovation.
Axplora, a manufacturing partner for small-molecule APIs and ADCs, has completed the first R&D batches of Axotecan, its project to establish an independent European source of Exatecan for ADC developers.
Leica Biosystems, a Danaher company, announced that the Company has completed its acquisition of privately held StatLab, a provider of pre-analytical consumables and equipment, from Linden Capital Partners and Audax Private Equity.
Vetter, a Contract Development and Manufacturing Organisation (CDMO), continues to expand its commercial fill-and-finish network to further strengthen its global manufacturing operations and support the evolving needs of pharma and biotech customers.
IMA Life North America, part of IMA Group, held a Grand Opening Ceremony in Tonawanda for the new 120,000-square-foot facility built to increase its production of freeze-drying equipment for the pharmaceutical industry.
Lonza Capsugel has announced a new integrated service offering designed to help pharmaceutical manufacturers assess and understand nitrite levels in empty capsules through nitrite testing supported by a validated analytical method.
Leica Biosystems announced the addition of two Paige digital pathology AI-enabled products from Tempus to its Aperio AI Store—a unified, interoperable digital pathology platform that provides multiple AI-powered applications in a single interface.
OGT, a provider of genomic research and diagnostic solutions has unveiled next-generation sequencing (NGS) automation capabilities across its SureSeq NGS portfolio, compatible with the Hamilton NGS STAR Line.
AB-BIOTICS will return to CPHI 2026 with an expanded portfolio of science-backed biotic solutions that target specific health indications across a range of life stages.
